Søgeord

Søgning på udtrykket 'hiv' giver 84 resultater

Dokumenter [7] Sider [8] Kalender [27] Nyt fra tidsskrifterne [20] Aktuelle smitsomme sygdomme [20]

Dokumenter [7]

Forfattere: Jan Gerstoft, Nina Weis, Terese L. Katzenstein (Dansk Selskab for Infektionsmedicin), Anders Nyboe Andersen og Jens Fedder (Dansk Fertilitetsselskab).

Endelig guideline: 01.09.2020 Version: 3 Guideline skal revideres senest: 01.09.2023 Arbejdsgruppens medlemmer: Peer Brehm Christensen, Christian Erikstrup, Jan Gerstoft, Terese Katzenstein, Alex Laursen, Suzanne Lunding, Birgitte Mørn og Nina Weis.

Fællesregional retningslinje for udlevering af forebyggende medicin mod HIV (PrEP), udgivet af Danske Regioner.

Senest revideret maj 2018. Arbejdsgruppen bestod af: Jan Gerstoft, Gitte Kronborg, Jens D. Lundgren, Henrik I. Nielsen, Olav Ditlevsen Larsen, Niels Obel, Alex Laursen, Ann-Brit Eg Hansen.

Europæisk guideline om hvornår, der bør testes for HIV. Udgivet af "HIV in Europe", et paneuropæisk initiativ for tidligere diagnosticering og behandling af HIV.

Senest revideret marts 2019. Arbejdsgruppen bestod af: Jan Gerstoft, Gitte Kronborg, Ann-Brit Eg Hansen, Jens D. Lundgren, Henrik I. Nielsen, Olav Ditlevsen Larsen, Niels Obel og Alex Laursen.

Anbefaling for profylakse og opfølgning af stikuheld og anden blodeksposition Arbejdsgruppe: Suzanne Lunding (formand), Peer Brehm Christensen, Christian Erikstrup, Terese L. Katzenstein, Henrik Krarup, Alex Lund Laursen, Birgitte Mørn og Nina Weis


Sider [8]

Formål | At kursisten skal opnå en forståelse af HIV-infektionen herunder viden om dens epidemiologi, patogenese, patofysiologi, diagnose, forebyggelse, behandlingsmuligheder og prognose samt viden om diagnostik og behandlingen af AIDS-definerende sygdomme og de hyppigste sexuelt overførte sygdomme. Tid og sted | Hvidovre Hospital. Lokale 10 i undervisningsbygningen Delkursusledere | Ann-Brit Eg Hansen og Ole Kirk Program Mandag 3. oktober | 10:00-10:15 Velkomst og introduktion …

…ologisk terrorisme. Specialet er karakteriseret ved et sygdomspanorama hvor sygdommenes prævalens såvel som incidens ændres hurtigt på lokalt og globalt plan. Over de seneste tyve år har specialet udviklet sig til at håndtere behandlingen af HIV og AIDS. I de seneste år er nye alvorlige infektionssygdomme som SARS, fugleinfluenza, West Nile virus, Hanta virus, Nipah virus, og Hendra virus tilkommet. Alvorlige sygdomme som hæmoragisk viral feber forårsaget af Ebola, Lassa, Dengue, Crimean-Co…

…epræsentanter i diverse arbejdsgrupper og udvalg, og publicerede guidelines. Antiretroviral terapi Henrik Nielsen, Jan Gerstoft, Jens Lundgren, Alex Laursen, Niels Obel, Olav Larsen, Gitte Kronborg, Ann-Brit Eg Hansen Antiviral behandling af hiv smittede personer Fertilitetsbehandling ved HIV og hepatitis B og C HIV behandling af gravide HIV post exposure profylakse (PEP) Pre-exposure profylakse mod HIV (PrEP) Borrelia Anne-Mette Lebech, Sigurdur Skarphedinsson Borrelia klar…

… 10 september 2021 Gastroenterologiske infektioner og kronisk hepatitis Dato for næste kursus Efterår 2023 Sted Hvidovre Hospital Delkursusledelse Morten HelmsPeer Brehm Christensen  Tidligere kurser 3. og 4. december 2020 HIV-infektion Dato for næste kursus 12. og 13. oktober 2022 (2 dage) Sted Endnu ikke afklaret Delkursusledelse Ole Schmeltz Søgaard og Lene Ryom Nielsen  Tidligere kurser 7. og 8. oktober 2019 3. og 4. oktober 2016 Immundefekt og feber…

…ologisk terrorisme. Specialet er karakteriseret ved et sygdomspanorama hvor sygdommenes prævalens såvel som incidens ændres hurtigt på lokalt og globalt plan. Over de seneste tyve år har specialet udviklet sig til at håndtere behandlingen af HIV og AIDS. I de seneste år er nye alvorlige infektionssygdomme som SARS, fugleinfluenza, West Nile virus, Hanta virus, Nipah virus, og Hendra virus tilkommet. Alvorlige sygdomme som hæmoragisk viral feber forårsaget af Ebola, Lassa, Dengue, Crimean-Co…

Formål | At kursisten skal opnå en forståelse af HIV-infektionen herunder viden om dens epidemiologi, patogenese, patofysiologi, diagnose, forebyggelse, behandlingsmuligheder og prognose samt viden om diagnostik og behandlingen af AIDS-definerende sygdomme og de hyppigste sexuelt overførte sygdomme. Tid og sted | Hvidovre Hospital. Lokale 10 i undervisningsbygningen Delkursusledere | Ann-Brit Eg Hansen og Ole Kirk Program Mandag 3. oktober | 10:00-10:15 Velkomst og introduktion …

Formål Rejsefondens formål er at yde økonomisk støtte til lægelige medlemmer af DSI med henblik på deltagelse på følgende kongresser: NSCMID, ECCMID, IDWeek, HIV og Hepatitis Nordic Conference, EACS/Glasgow HIV og CROI. Hvad kan der søges om? Der kan søges om økonomisk støtte til registreringsafgift, rejseudgifter og indlogering til de respektive kongresser. Det er ikke et krav at man har et videnskabeligt bidrag på kongressen. Man kan højest få tildelt støtte til én kongres årligt. Ud…


Kalender [27]

30.09.2021, Barcelona, Spanien
28.10.2020, Paris, Frankrig
25.10.2020, Glasgow, Skotland
13.05.2019, København, Odense, Aarhus
28.10.2018, Glasgow, Skotland
30.05.2018, Aarhus Universitshospital Skejby, gæstekantinen ved hovedindgangen, Palle Juul-Jensens Blvd. 99, Aarhus N
30.05.2018, Rom, Italien
25.04.2018, CHIP, Øster Allé 56, 5. sal (Persimune mødelokale), 2100 København Ø
16.03.2018, Værløse
8.06.2017, Hvidovre Hospital
23.10.2016, Glasgow, Skotland
3.10.2016, Hvidovre Hospital
3.06.2015, Barcelona, Spanien
2.11.2014, Glasgow, Skotland
22.04.2014, Auditorium 5, Hvidovre Hospital
26.03.2014, Barcelona, Spanien
20.03.2013, Rom, Italien
14.01.2013, Auditorium 2, Rigshospitalet

Nyt fra tidsskrifterne [20]

Der er mere end 20 resultater, måske du vil se flere resultater her?
BMJ Open
18.10.2021
Objective To determine the spectrum of cancers in adolescents and young adults (AYAs) living with and without HIV in South Africa. Design Cross-sectional study with cancer records provided by the National Cancer Registry (NCR) and HIV records from the National Health Laboratory Service (NHLS). Setting and participants The NHLS is the largest provider of pathology services in the South African public sector. The NCR is a division of the NHLS. We included AYAs (aged 10–24 years) diagnosed with cance…
International Journal of Infectious Diseases
16.10.2021
The latent viral reservoir is the main obstacle preventing HIV eradication, as the virus persists integrated in long-lived, quiescent cells. Immune stimulatory by their nature, vaccines have been evaluated as possible agents for “shock and kill” strategies, which rely on using latency reversing agents to activate HIV transcription and virion production in order to purge the reservoir.
Journal of Medical Virology
14.10.2021
Journal of Medical Virology, Accepted Article.
BMC Infectious Diseases
14.10.2021
Abstract Background The COVID-19 and HIV epidemics have exacerbated existing inequities among vulnerable groups and severely impacted communities of color. People living with HIV (PLWH), who may already face stigma or discrimination, are at risk of experiencing further stigma as a result of COVID-19, which can result in medical mistrust. Methods We performed…
BMC Infectious Diseases
14.10.2021
Abstract Background The COVID-19 and HIV epidemics have exacerbated existing inequities among vulnerable groups and severely impacted communities of color. People living with HIV (PLWH), who may already face stigma or discrimination, are at risk of experiencing further stigma as a result of COVID-19, which can result in medical mistrust. Methods We performed…
BMJ Open
13.10.2021
Introduction HIV programmes in sub-Saharan Africa are well funded but programmes for diabetes and hypertension are weak with only a small proportion of patients in regular care. Healthcare provision is organised from stand-alone clinics. In this cluster randomised trial, we are evaluating a concept of integrated care for people with HIV infection, diabetes or hypertension from a single point of care. Methods and analysis 32 primary care health facilities in Dar es Salaam and Kampala regions were randomise…
AIDS
13.10.2021
…g-acting formulations of cabotegravir (CAB) and rilpivirine (RPV) have demonstrated efficacy in Phase 3 studies. POLAR (NCT03639311) assessed antiviral activity and safety of CAB+RPV long-acting administered every 2 months (Q2 M) in adults living with HIV-1 who previously received daily oral CAB+RPV in LATTE (NCT01641809). Design: A phase 2b, multicenter, open-label, rollover study. Methods: LATTE participants with plasma HIV-1 RNA less than 50 copies ml−1 who completed at least 300 weeks …
AIDS
13.10.2021
Objective: To test an implementation strategy, the Systems Analysis and Improvement Approach (SAIA), to increase rates of HIV testing and counseling (HTC) in family planning (FP) clinics in Mombasa, Kenya. Design: Cluster randomized trial Methods: Twenty-four FP clinics were randomized 1:1 to implementing SAIA versus usual procedures. Study staff implemented monthly SAIA cycles with FP clinic staff for 12 months. SAIA has five steps. Step 1 uses a “cascade analysis” tool to quantify the number…
AIDS
13.10.2021
Objective: To understand the prevalence of HIV-associated wasting (HIVAW) in the US. Design: Medical and pharmacy claims study using IBM® MarketScan® Commercial, Medicare Supplemental and Medicaid Databases. Methods: Study period: 7/2012–9/2018 (first HIV diagnosis claim = HIV index date). People living with HIV (PLWH) were excluded if they were aged 
AIDS
13.10.2021
Objective(s): To estimate the incidence of neonatal mortality among infants born to women living with HIV in the UK and Ireland in 1998–2017, describe causes of neonatal death (NND) and examine risk factors. Design: Population-based surveillance of pregnancies in diagnosed women living with HIV and their infants in the UK and Ireland. Methods: Estimated yearly incidence of NND was reported for 1998–2017 and causes coded using the World Health Organization International Classification of Perinata…
AIDS
13.10.2021
Objective: This study was designed to provide information on the genetic diversity of HIV-1 and drug resistance mutations in Nigeria, as there is limited understanding of variants circulating in the country. Methods: We used an advanced next-generation sequencing platform, Primer ID, to: investigate the presence of high and low abundance drug resistance mutations; characterize pre-existing INSTI mutations in ART-experienced but dolutegravir-naive individuals; detect recent HIV-1 infections and characte…
BMJ Open
12.10.2021
Introduction Cardiovascular diseases (CVDs) are the single greatest contributor to global mortality. The successful introduction and scale-up of antiretroviral therapy (ART) delivered a reduction in HIV mortality. Consequently, an association was found between the scale-up of ART and an increased prevalence of comorbidities among people living with HIV (PLWH) such as hypertension and dyslipidaemia. A higher quality diet can delay the onset of comorbidities related to HIV infection. Diet quality and its meth…
Tropical Medicine & International Health
12.10.2021
Tropical Medicine & International Health, Accepted Article.
Tropical Medicine & International Health
12.10.2021
Tropical Medicine & International Health, Accepted Article.
Journal of Medical Virology
12.10.2021
Journal of Medical Virology, Accepted Article.
PLoS One Infectious Diseases
11.10.2021
…Ishizaki, Xiuqiong Bi, Kazunori Matsuda, Lam Van Nguyen, Hung Viet Pham, Chung Thi Thu Phan, Thuy Thi Bich Phung, Tuyen Thi Thu Ngo, An Van Nguyen, Dung Thi Khanh Khu, Hiroshi Ichimura Objective We investigated the impact of human immunodeficiency virus (HIV) infection and anti-retroviral therapy (ART) on the gut microbiota of children. Design This cross-sectional study investigated the gut microbiota of children with and without HIV. Methods We collected fecal samples from 59 children with HIV (29 treat…
Antimicrobial Agents And Chemotherapy
11.10.2021
Antimicrobial Agents and Chemotherapy, <a href="https://journals.asm.org/toc/aac/0/ja">Volume 0, Issue ja</a>, -Not available-.
Journal of Acquired Immune Deficiency Syndromes
9.10.2021
Background: HIV pre-exposure prophylaxis (PrEP) requires continued use at an effective dosage to reduce HIV incidence. Data suggest early PrEP drop-off among many populations. We sought to describe PrEP use over the first year among racial and ethnic minority patients in the US. Setting: Racial and ethnic minority patients initiating PrEP at a federally qualified health center in Chicago, IL Methods: Using electronic health records, we determined the adherence (≥6 weekly doses) trajectories over t…
Journal of Acquired Immune Deficiency Syndromes
9.10.2021
No abstract available
Journal of Acquired Immune Deficiency Syndromes
9.10.2021
Background: Brain derived neurotrophic factor (BDNF) shows consistent associations with memory across many clinical populations, including dementia. Less is understood about the association between BDNF and memory functioning in people living with HIV (PWH). Methods: A sample of 173 adults aged 50+ (n=100 HIV+ and n=73 HIV seronegative) completed a comprehensive neurobehavioral assessment and blood draw. Linear regressions predicting memory domains (learning, delayed recall, recognition) were conducted…

Aktuelle smitsomme sygdomme [20]

Der er mere end 20 resultater, måske du vil se flere resultater her?
Eurosurveillance latest updates
23.09.2021
…treatment as prevention (TasP) effect, transmission of hepatitis C virus (HCV) persists in men who have sex with men (MSM) who engage in high-risk sexual behaviours. Aim We aimed to estimate the incidence of primary HCV infection among MSM living with HIV in France when DAA was readily available. Methods We used data from a large French hospital cohort of persons living with HIV (ANRS CO4-FHDH) prospectively collected between 2014 and 2017. HCV incidence rates were calculated using person-time metho…
Medscape Infectious Diseases
16.09.2021
Of the 20 members of the President's Advisory Council on HIV/AIDS, 10 are Black Americans, reflecting the disproportionate impact HIV has had on Black communities.
Medscape Infectious Diseases
16.09.2021
It was people like Rashidah Abdul-Khabeer, PhD, a Black Muslim nurse in a headscarf who spent the early 1980s going to bars for gay Black men, teaching them to put condoms on with their teeth.
Medscape Infectious Diseases
26.08.2021
Using EHR records of 13,900 adults linked to HIV pre-exposure prophylaxis, researchers found that patients were most likely to stop using PrEP within the first 2 years of receiving the prescription.
Eurosurveillance latest updates
19.08.2021
Background The assumption that migrants acquire human immunodeficiency virus (HIV) before migration, particularly those from high prevalence areas, is common. Aim We assessed the place of HIV acquisition of migrants diagnosed in four European countries using surveillance data. Methods Using CD4+ T-cell count trajectories modelled to account for seroconversion bias, we estimated infection year of newly HIV-diagnosed migrants residing in the United Kingdom (UK), Belgium, Sweden and Italy with a kn…
Medscape Infectious Diseases
20.07.2021
Side effects from once-daily islatravir plus doravirine are short-lived and mild.
Medscape Infectious Diseases
13.07.2021
As the world begins to make sense of the impact of COVID-19 on health, HIV researchers get back to the work of optimizing treatments and tackling the structural barriers that keep patients sick.
Medscape Infectious Diseases
6.07.2021
Aid agencies have distributed a strawberry-flavoured tablet for children living with HIV in six African countries, the first generic pediatric version of a key antiretroviral, global health agency UNITAID said on Sunday.
Morbidity and Mortality Weekly Report (MMWR)
1.07.2021
Male circumcision is an important preventive strategy in lifelong partial protection against heterosexually acquired HIV infection among males. This report describes how the prevalence of male circumcision increased in Chókwè District in southern Mozambique.
Morbidity and Mortality Weekly Report (MMWR)
24.06.2021
This report describes HIV testing trends in people with commercial insurance or Medicaid.
Eurosurveillance latest updates
24.06.2021
Background Recent and reliable estimates on the prevalence of coinfection with human immunodeficiency virus (HIV) and hepatitis B virus (HBV) in Europe are lacking. Aim Leveraged on a study designed to assess HIV/HCV coinfection prevalence, we assessed the prevalence of HIV/HBV coinfection in Spain in 2018 and compared the results with five similar studies performed since 2002. Methods This cross-sectional prevalence study was carried out in 43 centres, and patients were selected using simple random s…
ProMED
15.06.2021
Other Human Disease -- South AfricaAbstract--------An HIV-positive man from Zimbabwe living in South Africa sought treatment for multiple clinical signs, including fever, weight loss, anemia, and splenomegaly. We identified in his blood an African rodent piroplasm, _Anthemosoma garnhami_, related to _Babesia_ species. This finding extends the known geographic and host range of _A. garnhami_. A 24-year-old man from Zimbabwe complaining of a 3-month period of generalized body pains, drenching night sweats, an…
Medscape Infectious Diseases
11.06.2021
Despite significant advances in HIV research, prevention, and treatment, HIV is still criminalized both in the U.S. and abroad. Is this the ultimate challenge to ending the epidemic?
Eurosurveillance latest updates
10.06.2021
Human immunodeficiency virus (HIV) pre-exposure prophylaxis (PrEP), the use of antiretroviral medication to prevent HIV acquisition, is a highly effective biomedical prevention tool. The World Health Organization (WHO) recommends PrEP for people at substantial risk of HIV infection, as part of combination prevention, and highlights the need for robust evaluation of PrEP programmes. Based on suggested WHO core indicators, we created a concise set of HIV PrEP-related dataset variables, to harmonise the monito…
Morbidity and Mortality Weekly Report (MMWR)
3.06.2021
This report describes how HIV-positive patients with severe HIV disease were more likely to develop severe COVID-19 or die of COVID-19.
Morbidity and Mortality Weekly Report (MMWR)
3.06.2021
This report describes estimated HIV infections in the United States during 1981-2019.
Morbidity and Mortality Weekly Report (MMWR)
27.05.2021
This report describes the impact of COVID-19 on HIV viral load testing in PEPFAR-supported countries.
Morbidity and Mortality Weekly Report (MMWR)
27.05.2021
This report describes how Sub-Saharan African countries have overcome challenges to initiate and scale up HIV viral load testing to monitor patients receiving Antiretroviral therapy.
ProMED
2.05.2021
HIV/AIDS -- United States"Lowering the number of new HIV infections among transgender women is a major HIV prevention goal [1]. This goal can be achieved by implementing 3 important strategies for reducing HIV infections: (1) intensifying HIV prevention efforts in populations where HIV is most heavily concentrated, including transgender women; gay, bisexual, and other men who have sex with men (hereafter referred to as MSM); black or African American persons; Hispanic or Latino persons; and persons who inje…
Medscape Infectious Diseases
21.04.2021
Public health resources have shifted from one pandemic to the other, and experts fear steep declines in testing and diagnoses mean more people will contract HIV and die of AIDS.

Nyhedsbrev

Skriv din email adresse og modtag nyheder om hjemmesiden.


© 2021 Dansk Selskab for Infektionsmedicin

version: 2.9.0 ● design: C P Fischer

Side indlæst på 1,256 s

Cookies og privatliv